Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Pharma
Merck, AstraZeneca, Astellas—Fierce Pharma Asia
Merck and AZ suffered losses in China. Astellas shuffled its C-suite and revealed a slowdown for its newly launched eye disease med Izervay. Plus more.
Angus Liu
Feb 7, 2025 9:00am
AstraZeneca logs China sales decline in Q4 amid probes
Feb 6, 2025 10:31am
GSK raises long-term sales goal—again—despite vaccines woes
Feb 5, 2025 11:06am
Merck halts Gardasil shipments to China, pulls $11B sales target
Feb 4, 2025 12:10pm
CDMO Joinn wraps up purchase of Lonza biologics plant in China
Jan 23, 2025 9:45am
BioDuro expands peptide production in China with new facility
Jan 13, 2025 9:35am